AKT1 and hepatocellular carcinoma: Additionally, melittin treatment reported downregulated Akt phosphorylation, which indicated the inhibitory potential of melittin in hepatocellular carcinoma via the inhibition of the PI3K/Akt cell signaling pathway [46].